Pharma & Biotech
FSD Pharma throws resources behind legacy anti-inflammatory drug as potential coronavirus therapy
Cardiol Therapeutics is advancing its proprietary pharmaceutical cannabidiol therapeutics program to treat life-threatening heart disease
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.